Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.39 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FABP3 | P05413 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1992844 | 0.84 | EPHX2 (0.44) | CES2CES1EPHX2TDP1SOAT1 | |
| SCHEMBL820706 | 0.84 | CES2 (0.46) | CES2CES1EPHX2TDP1SOAT1 | |
| SCHEMBL1992846 | 0.82 | EPHX2 (0.44) | CES2CES1EPHX2TDP1SOAT1 | |
| SCHEMBL7052060 | 0.82 | EPHX2 (0.44) | CES2CES1EPHX2TDP1SOAT1 | |
| SCHEMBL9679131 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A | |
| Zinc Ion SCHEMBL10726528 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A | |
| Zinc Ion SCHEMBL9704026 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A | |
| SCHEMBL19210221 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A | |
| SCHEMBL194236 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A | |
| SCHEMBL10731314 | 0.81 | FABP3 (0.50) | CES2CES1TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8735494-B2 | Polymers functionalized with nitrile compounds containing a protected amino group | BRIDGESTONE CORPORATION (JP) | 2014-05-27 | — | — | US | claimed |
| US-20250066516-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2025-02-27 | — | — | US | disclosed |
| EP-4457250-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | Bridgestone Corporation (JP) | 2024-11-06 | — | — | EP | disclosed |
| US-20240336717-A1 | FUNCTIONALIZED POLYMERS HAVING THERMORESPONSIVE BEHAVIOR | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC | 2024-10-10 | — | — | US | disclosed |
| US-12054573-B2 | Functionalized polymers having thermoresponsive behavior | BRIDGESTONE CORPORATION (JP) | 2024-08-06 | — | — | US | disclosed |
| EP-3052531-B1 | POLYMERS FUNCTIONALIZED WITH IMINE COMPOUNDS CONTAINING A CYANO GROUP | BRIDGESTONE CORP (JP) | 2024-07-24 | — | — | EP | disclosed |
| WO-2023129959-A1 | HYDROGENATED POLYBUTADIENE POLYMERS AND RUBBER COMPOSITIONS INCORPORATING SAME | BRIDGESTONE CORPORATION (JP) | 2023-07-06 | — | — | WO | disclosed |
| US-20230144912-A1 | METAL-BASED CATALYST FOR PRODUCING POLYDIENES | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC | 2023-05-11 | — | — | US | disclosed |
| EP-3456746-B1 | TERMINAL-MODIFIED CONJUGATED DIENE-BASED POLYMER, RUBBER COMPOSITION, AND RUBBER ARTICLE | BRIDGESTONE CORP (JP) | 2023-04-19 | — | — | EP | disclosed |
| EP-4126983-A1 | METAL-BASED CATALYST FOR PRODUCING POLYDIENES | Bridgestone Americas Tire Operations, LLC (US) | 2023-02-08 | — | — | EP | disclosed |
| WO-2010085622-A2 | POLYMERS FUNCTIONALIZED WITH NITRILE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2010-07-29 | — | — | WO | disclosed |
| US-20100168378-A1 | POLYMERS FUNCTIONALIZED WITH NITROSO COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2010-07-01 | — | — | US | disclosed |
| US-20100004414-A1 | POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| WO-2010002849-A1 | POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP | BRIDGESTONE CORPORATION (JP) | 2010-01-07 | — | — | WO | disclosed |
| US-7294680-B2 | Method of producing conjugated diene polymers with narrow molecular weight distribution and polymer produced | JSR CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| US-20060287433-A1 | Thermoplastic elastomer composition and molding thereof | JSR CORPORATION (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1683832-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MOLDING THEREOF | JSR Corporation (JP) | 2006-07-26 | — | — | EP | disclosed |
| US-20040147694-A1 | Method of producing conjugated diene polymers with narrow molecular weight distribution and polymer produced | JSR CORPORATION | 2004-07-29 | — | — | US | disclosed |
| EP-0863165-B1 | Method of producing conjugated diene polymers | JSR CORP (JP) | 2003-06-04 | — | — | EP | disclosed |
| EP-0863165-A1 | Method of producing conjugated diene polymers | JSR Corporation (JP) | 1998-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004414-A1 | POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP | PARG, PIN1, NPEPPS | CES2 2565/4885CES1 4704/4885EPHX2 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.